Victoria Ullah
AstraZeneca (Netherlands)(NL)AstraZeneca (Finland)(FI)
Publications by Year
Research Areas
Asthma and respiratory diseases, Ion channel regulation and function, Inflammatory mediators and NSAID effects, Estrogen and related hormone effects, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile(2018)73 cited
- → Dynamic allosteric communication pathway directing differential activation of the glucocorticoid receptor(2020)43 cited
- → Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma(2021)35 cited
- → Identification of pyrazolo-pyrimidinones as GHS-R1a antagonists and inverse agonists for the treatment of obesity(2012)25 cited
- → Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma(2019)22 cited
- → Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors(2011)8 cited
- → Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor(2012)7 cited
- → An Investigation of Phosphinamides as a Functional Group for Medicinal Chemistry(2025)
- → CCDC 1884583: Experimental Crystal Structure Determination(2019)